Pituitary apoplexy following adenoviral vector-based COVID-19 vaccination.

COVID-19 Vaccine AstraZeneca COVID-19, Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) MRI, Magnetic resonance imaging Magnetic resonance imaging (MRI) Menstrual changes PA, Pituitary apoplexy Pituitary apoplexy VITT, Vaccine-induced immune thrombotic thrombocytopenia Vaxzevria®

Journal

Brain hemorrhages
ISSN: 2589-238X
Titre abrégé: Brain Hemorrhages
Pays: Netherlands
ID NLM: 101763734

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 26 03 2022
revised: 09 04 2022
accepted: 13 04 2022
pubmed: 26 4 2022
medline: 26 4 2022
entrez: 25 4 2022
Statut: ppublish

Résumé

Pituitary apoplexy (PA) may complicate the course of coronavirus disease 2019 (COVID-19), posing a potential threat to life. Among vaccines designed to prevent COVID-19, there are those adenoviral vector-based, such as Vaxzevria® (formerly COVID-19 Vaccine AstraZeneca). The product insert states that it can cause very rare coagulation disorders, in particular thrombosis with thrombocytopenia syndrome in some cases accompanied by bleeding, cerebrovascular venous or sinus thrombosis, and thrombocytopenia, including immune thrombocytopenia, also associated with bleeding. Here, we report the onset of PA after Vaxzevria® in a 28-year-old healthy Caucasian female, who experienced long-lasting tension-type headache, hyperprolactinemia and menstrual changes, without thrombocytopenia or thrombosis.

Identifiants

pubmed: 35464129
doi: 10.1016/j.hest.2022.04.002
pii: S2589-238X(22)00015-8
pmc: PMC9017089
doi:

Types de publication

Journal Article

Langues

eng

Pagination

27-29

Informations de copyright

© 2022 International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Med Clin (Barc). 2022 May 27;158(10):498-499
pubmed: 34895747
World Neurosurg. 2021 Aug;152:e678-e687
pubmed: 34129968
BMJ. 2022 Jan 26;376:o142
pubmed: 35082132
Pituitary. 2021 Jun;24(3):465-481
pubmed: 33939057
J Thromb Haemost. 2022 Jan;20(1):149-156
pubmed: 34693641

Auteurs

Luca Roncati (L)

Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplantation, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Antonio Manenti (A)

Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplantation, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Classifications MeSH